These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10689627)

  • 1. Otilonium bromide: a selective spasmolytic for the gastrointestinal tract.
    Evangelista S
    J Int Med Res; 1999; 27(5):207-22. PubMed ID: 10689627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of otilonium bromide on contractile patterns in the human sigmoid colon.
    Gallego D; Aulí M; Aleu J; Martínez E; Rofes L; Martí-Ragué J; Jiménez M; Clavé P
    Neurogastroenterol Motil; 2010 Jun; 22(6):e180-91. PubMed ID: 20367799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts.
    Lindqvist S; Hernon J; Sharp P; Johns N; Addison S; Watson M; Tighe R; Greer S; Mackay J; Rhodes M; Lewis M; Stebbings W; Speakman C; Evangelista S; Johnson I; Williams M
    Br J Pharmacol; 2002 Dec; 137(7):1134-42. PubMed ID: 12429587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy.
    Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Pescatori M; Anastasio G
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):60-3. PubMed ID: 1756285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies on otilonium bromide.
    Giachetti A
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):56-9. PubMed ID: 1661629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome.
    Evangelista S
    Curr Pharm Des; 2004; 10(28):3561-8. PubMed ID: 15579053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Otilonium bromide-diazepam in the treatment of the irritable colon. A controlled study versus otilonium bromide].
    Mollica G; Manno G
    Clin Ter; 1992 Aug; 141(8):129-34. PubMed ID: 1395455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of otilonium bromide (OB) in human cultured smooth muscle cells and rat colonic strips.
    Martínez-Cutillas M; Gil V; Gallego D; Mañé N; Martín MT; Jiménez M
    Neurogastroenterol Motil; 2013 Dec; 25(12):e803-12. PubMed ID: 23941257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otilonium Bromide: A Drug with a Complex Mechanism of Action.
    Evangelista S; Traini C; Vannucchi MG
    Curr Pharm Des; 2018; 24(16):1772-1779. PubMed ID: 29732965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritable bowel syndrome: focus on otilonium bromide.
    Boeckxstaens G; Clavé P; Corazziari ES; Tack J
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):131-7. PubMed ID: 24417261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.
    Battaglia G; Morselli-Labate AM; Camarri E; Francavilla A; De Marco F; Mastropaolo G; Naccarato R
    Aliment Pharmacol Ther; 1998 Oct; 12(10):1003-10. PubMed ID: 9798806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the action of otilonium bromide and pinaverium bromide: study conducted under clinical control.
    Defrance P; Casini A
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):64-6. PubMed ID: 1756286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.
    Forte E; Pizzoferrato M; Lopetuso L; Scaldaferri F
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):25-37. PubMed ID: 22338545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of spasmolytic agent otilonium bromide (spasmomen) in digestive endoscopy: a prospective study in 63 patients].
    Gómez NA; León CJ; Gutiérrez J
    Acta Gastroenterol Latinoam; 1997; 27(3):123-5. PubMed ID: 9412140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome.
    Glende M; Morselli-Labate AM; Battaglia G; Evangelista S
    Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1331-8. PubMed ID: 12468954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study.
    Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Marzio L; Di Felice F
    Hepatogastroenterology; 1992 Oct; 39(5):392-5. PubMed ID: 1459516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antispasmodics in the treatment of irritable bowel syndrome.
    Annaházi A; Róka R; Rosztóczy A; Wittmann T
    World J Gastroenterol; 2014 May; 20(20):6031-43. PubMed ID: 24876726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of irritable bowel syndrome with dicetelium and spasmomen].
    Nedogoda SV; Parshev VV
    Klin Med (Mosk); 2000; 78(10):42-6. PubMed ID: 11220900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The otilonium bromide-benzodiazepine combination in the therapy of the irritable colon syndrome].
    Capurso L; Del Sette F; Ferrario F; Tarquini M
    Clin Ter; 1992 Aug; 141(8):121-7. PubMed ID: 1395454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.